cancer_study_identifier: mel_iatlas_gide_2019
type_of_cancer: mel
name: Metastatic Melanoma (Immunotherapy Trial, Cancer Cell 2019) - iAtlas Harmonized
pmid: 30753825
reference_genome: hg38
citation: Gide et al. Cancer Cell 2019
description: Whole-exome sequencing and neoantigen landscape analysis of 158 metastatic melanomas treated with anti-PD-1 monotherapy or combined anti-PD-1 and anti-CTLA-4 therapy and their matched normals. A subset of these patients were treated as part of clinical trials. The reprocessing of raw sequencing data is coordinated by <a href="https://cri-iatlas.org/">CRI iAtlas</a>.

